New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases

被引：42
|
作者：
Mastalerz, Harold
Chang, Ming
Chen, Ping
Dextraze, Pierre
Fink, Brian E.
Gavai, Ashvinikumar
Goyal, Bindu
Han, Wen-Ching
Johnson, Walter
Langley, David
Lee, Francis Y.
Marathe, Punit
Mathur, Arvind
Oppenheimer, Simone
Ruediger, Edward
Tarrant, James
Tokarski, John S.
Vite, Gregory D.
Vyas, Dolatrai M.
Wong, Henry
Wong, Tai W.
Zhang, Hongjian
Zhang, Guifen
机构：
[1] Dept Oncol Chem, Wallingford, CT 06492 USA
[2] Dept Discovery Biol, Wallingford, CT 06492 USA
[3] Dept Pharmaceut Candidate Optimizat, Wallingford, CT 06492 USA
[4] Dept Comp Aided Drug Design, Wallingford, CT 06492 USA
[5] Dept Chem Synth, Wallingford, CT 06492 USA
[6] Bristol Myers Squibb Pharmaceut Inst, Princeton, NJ 08543 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 07期
关键词：
EGFR; HER2; receptor tyrosine kinase inhibitor; pyrrolotriazine;
D O I：
10.1016/j.bmcl.2007.01.002
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Novel C-5 substituted pyrrolotriazines were optimized for dual EGFR and HER2 protein tyrosine kinase inhibition. The lead compound exhibited promising oral efficacy in both EGFR and HER2 driven human tumor xenograft models. It is hypothesized that its C-5 morpholine side chain binds in the ribose phosphate portion of the ATP binding pocket. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2036 / 2042
页数：7
相关论文
共 50 条
  • [21] Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer
    Dhiwar, Prasad Sanjay
    Matada, Gurubasavaraja Swamy Purwarga
    Raghavendra, Nulgumnalli Manjunathaiah
    Ghara, Abhishek
    Singh, Ekta
    Abbas, Nahid
    Andhale, Ganesh Sakaram
    Shenoy, Ganesh Prasad
    Sasmal, Pujan
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (09) : 1401 - 1413
  • [22] Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases
    Suzuki, Naoyuki
    Shiota, Takeshi
    Watanabe, Fumihiko
    Haga, Norihiro
    Murashi, Takami
    Ohara, Takafumi
    Matsuo, Kenji
    Omori, Naoki
    Yari, Hiroshi
    Dohi, Keiji
    Inoue, Makiko
    Iguchi, Motofumi
    Sentou, Jyunko
    Wada, Tooru
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 456 - 460
  • [23] Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer
    Jethwa, Megha
    Gangopadhyay, Aditi
    Saha, Achintya
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2024, 11
  • [24] 2-substituted 4-aminoquinazoline derivatives as potential dual inhibitors of EGFR and HER2: an in silico and in vitro study
    Sangande, Frangky
    Julianti, Elin
    Tjahjono, Daryono Hadi
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (05) : 762 - 771
  • [25] RECEPTOR TYROSINE KINASES IN SINONASAL UNDIFFERENTIATED CARCINOMAS-EVALUATION FOR EGFR, c-KIT, AND HER2/neu EXPRESSION
    Chernock, Rebecca D.
    Perry, Arie
    Pfeifer, John D.
    Holden, Joseph A.
    Lewis, James S., Jr.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (07): : 919 - 927
  • [26] 2-substituted 4-aminoquinazoline derivatives as potential dual inhibitors of EGFR and HER2: an in silico and in vitro study
    Frangky Sangande
    Elin Julianti
    Daryono Hadi Tjahjono
    Medicinal Chemistry Research, 2022, 31 : 762 - 771
  • [27] Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors
    Alsaid, Mansour S.
    Al-Mishari, Abdullah A.
    Soliman, Aiten M.
    Ragab, Fatma A.
    Ghorab, Mostafa M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 141 : 84 - 91
  • [28] Novel sulphonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers
    Soliman, Aiten M.
    Alqahtani, Ali S.
    Ghorab, Mostafa
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 1030 - 1040
  • [29] Synthesis and biological evaluation of new series of quinazoline derivatives as EGFR/HER2 dual-target inhibitors
    Jiao, Xiaoyu
    Zhang, Qing
    Zhang, Yue
    Shao, Junlan
    Ding, Lei
    Tang, Chunlei
    Feng, Bainian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 67
  • [30] Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors
    Sever, Belgin
    Altintop, Mehlika Dilek
    Radwan, Mohamed O.
    Ozdemir, Ahmet
    Otsuka, Masami
    Fujita, Mikako
    Ciftci, Halil I.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182
12345